Medical Researchers Want Up To Five Years Exclusivity For Clinical Trial Data Derived From Volunteers | Techdirt

peter.suber's bookmarks 2017-02-25

Summary:

"A year ago, we wrote about how TPP's requirement for "data exclusivity" risked undermining one of science's fundamental principles: that facts cannot be owned. Data exclusivity is just the latest attempt by Big Pharma to extend its monopoly over drugs, whether using patents or other means. To a certain extent, you might expect that: after all, companies are designed to maximize profits, and if it means more people suffer or die along the way, well, that's regrettable but sort of beside the point. However, it's surprising to see a group of medical researchers writing in the prestigious New England Journal of Medicine (NEJM) calling for just the same kind of data exclusivity. The post is in response to an earlier NEJM article by the International Committee of Medical Journal Editors (ICMJE), entitled "Sharing Clinical Trial Data"...."

Link:

https://www.techdirt.com/articles/20160804/08460835154/medical-researchers-want-up-to-five-years-exclusivity-clinical-trial-data-derived-volunteers.shtml

From feeds:

Open Access Tracking Project (OATP) ยป peter.suber's bookmarks

Tags:

oa.pharma oa.medicine oa.data oa.obstacles oa.monopoly

Date tagged:

02/25/2017, 16:31

Date published:

02/25/2017, 11:31